Cite
Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma.
MLA
Martinelli, Giovanni, et al. “Chlorambucil in Combination with Induction and Maintenance Rituximab Is Feasible and Active in Indolent Non-Hodgkin’s Lymphoma.” British Journal of Haematology, vol. 123, no. 2, Oct. 2003, p. 271. EBSCOhost, https://doi.org/10.1046/j.1365-2141.2003.04586.x.
APA
Martinelli, G., Danielem Laszlo, G., Bertolini, F., Pastano, R., Mancuso, P., Calleri, A., Vanazzi, A., Santoro, P., Cavalli, F., & Zucca, E. (2003). Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin’s lymphoma. British Journal of Haematology, 123(2), 271. https://doi.org/10.1046/j.1365-2141.2003.04586.x
Chicago
Martinelli, Giovanni, Giovanni Danielem Laszlo, Francesco Bertolini, Rocco Pastano, Patrizia Mancuso, Angelica Calleri, Anna Vanazzi, Paola Santoro, Franco Cavalli, and Emanuelle Zucca. 2003. “Chlorambucil in Combination with Induction and Maintenance Rituximab Is Feasible and Active in Indolent Non-Hodgkin’s Lymphoma.” British Journal of Haematology 123 (2): 271. doi:10.1046/j.1365-2141.2003.04586.x.